School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 3 Sassoon Road, Hong Kong, China.
School of Nursing, Nanjing Medical University, Nanjing, China.
Health Qual Life Outcomes. 2022 Jul 2;20(1):102. doi: 10.1186/s12955-022-02010-z.
The 12-item MOS Short-form Health Survey version 2 (SF-12v2) and the Veterans RAND 12-item Health Survey (VR-12) are generic health-related quality of life measures. They are fairly similar, but their differences in scores have not been assessed. Therefore, this study aimed to assess the differences between the SF-12v2 and the VR-12 in a Chinese population.
We conducted a household survey of 500 Chinese adults in Hong Kong. Both the SF-12v2 and the VR-12 were self-administered. The physical component summary score (PCS) and the mental component summary score (MCS) of each instrument were computed using well established algorithms. Their mean differences were assessed using 95% confidence interval (CI), and their individual differences were assessed by Bland-Altman analysis.
The participants had a mean age of 38 years (range: 18-80 years). The mean PCS and MCS scores of the SF-12v2 were 50.3 (SD = 6.5) and 49.0 (SD = 9.0), while those of the VR-12 were 49.6 (SD = 6.2) and 49.7 (SD = 8.8), respectively. The corresponding paired differences (SF-12v2-VR-12) of the PCS and MCS were 0.8, 95% CI (0.4-1.1) and - 0.7, 95% CI (- 1.2 to - 0.2), respectively. All confidence limits fell within the minimal clinical important difference (MCID) of 3. The 95% limits of agreement were - 7.0, 8.5 for PCS and - 11.2, 9.9 for MCS, which fell outside the corresponding MCID for individual responses.
The SF-12v2 and the VR-12 reached mean equivalence at the group sample level, but there was a range of individual differences.
12 项 MOS 简短健康调查版本 2(SF-12v2)和退伍军人 RAND12 项健康调查(VR-12)是通用的健康相关生活质量测量方法。它们相当相似,但它们的分数差异尚未评估。因此,本研究旨在评估 SF-12v2 和 VR-12 在中国人群中的差异。
我们在香港对 500 名中国成年人进行了家庭调查。SF-12v2 和 VR-12 均为自我管理。使用成熟的算法计算每个工具的物理成分综合得分(PCS)和心理成分综合得分(MCS)。使用 95%置信区间(CI)评估它们的平均差异,并使用 Bland-Altman 分析评估它们的个体差异。
参与者的平均年龄为 38 岁(范围:18-80 岁)。SF-12v2 的平均 PCS 和 MCS 得分为 50.3(SD=6.5)和 49.0(SD=9.0),而 VR-12 的得分为 49.6(SD=6.2)和 49.7(SD=8.8)。PCS 和 MCS 的相应配对差异(SF-12v2-VR-12)分别为 0.8,95%CI(0.4-1.1)和-0.7,95%CI(-1.2 至-0.2)。所有置信区间均落在最小临床重要差异(MCID)的 3 以内。PCS 的 95%一致性区间为-7.0,8.5,MCS 的 95%一致性区间为-11.2,9.9,这两个区间都超出了个体反应的相应 MCID。
SF-12v2 和 VR-12 在组样本水平上达到了平均等效性,但存在一定范围的个体差异。